Indeed, in a KrasG12D-driven PDAC mouse model, genetic ablation of autophagy results in increased tumor initiation, however, these tumors are lacking the ability to progress into adenocarcinomas, thus leading to improved survival irrespective of the p53 tumor suppressor status [33]. The gene discussed is TP53; the disease is neoplasm.